semaglutide fda approval US approves weight loss drug Wegovy to prevent cardiovascular events Semaglutide shortage ends as FDA
Description
Semaglutide is a GLP-1 receptor agonist that mimics a natural hormone controlling appetite and blood sugar

Kessler offers a comprehensive guide to weight loss

Diabetes Obes Metab 20(4):985997

[14] The injection is generally well tolerated

and is a co-author on a paper reporting a secondary analysis of data from the ACTION-IO study (funded by Novo Nordisk) (no payments received)
